Description:

Framework Agreement for the Purchase of IVF Medication

See II.1.1)

Short-acting pure FSH containing recombinant gonadotropins - 80% share

See II.2.1)

Short-acting pure FSH containing recombinant gonadotropins - 20% share

See II.2.1)

Combination of short-acting pure FSH and pure LH with 2:1 FSH:LH activity

See II.2.1)

Human menopausal gonadotrophins with a 1: 1 FSH: LH activity

See II.2.1)

Long-acting recombinant FSH

See II.2.1)

GnRH antagonists

See II.2.1)

Short-acting injectable GnRH agonists

See II.2.1)

Follitropin Delta - Biosynthetic FSH

See II.2.1)

Download full details as .pdf

The Buyer:

AZ Sint-Jan Brugge-Oostende AV

CPV Code(s):

33600000 - Pharmaceutical products